Alexandria Real Estate Equities, Inc. (NYSE:ARE) Receives $52.85 Average Price Target from Analysts

Alexandria Real Estate Equities, Inc. (NYSE:ARE) has received a consensus rating of “Reduce” from the sixteen ratings firms that are presently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating on the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $52.8462.

Several equities research analysts have recently commented on ARE shares. Citizens Jmp reiterated a “market perform” rating on shares of Alexandria Real Estate Equities in a research report on Monday, August 17th. BMO Capital Markets lifted their target price on shares of Alexandria Real Estate Equities from $52.00 to $54.00 and gave the stock a “market perform” rating in a report on Friday, June 12th. Robert W. Baird upped their price target on Alexandria Real Estate Equities from $46.00 to $52.00 and gave the company a “neutral” rating in a research note on Monday, August 24th. Morgan Stanley reiterated an “underweight” rating and issued a $53.00 price target on shares of Alexandria Real Estate Equities in a research report on Thursday, June 11th. Finally, Wall Street Zen lowered shares of Alexandria Real Estate Equities from a “hold” rating to a “sell” rating in a research note on Saturday, August 8th.

Alexandria Real Estate Equities Trading Up 5.3%

Shares of ARE stock opened at $56.33 on Friday. Alexandria Real Estate Equities has a 12-month low of $39.41 and a 12-month high of $88.24. The company has a market capitalization of $9.82 billion, a P/E ratio of -9.30 and a beta of 1.15. The firm has a 50-day moving average price of $50.86 and a 200 day moving average price of $49.35. The company has a quick ratio of 0.19, a current ratio of 0.19 and a debt-to-equity ratio of 0.67.

Alexandria Real Estate Equities (NYSE:ARE) last announced its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.43) EPS for the quarter, missing the consensus estimate of $0.09 by ($0.52). The business had revenue of $662.78 million for the quarter, compared to the consensus estimate of $464.86 million. Alexandria Real Estate Equities had a negative return on equity of 5.21% and a negative net margin of 36.08%.Alexandria Real Estate Equities’s revenue for the quarter was down 13.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.33 EPS. Alexandria Real Estate Equities has set its FY 2026 guidance at 6.350-6.450 EPS. Research analysts forecast that Alexandria Real Estate Equities will post 6.39 earnings per share for the current fiscal year.

Alexandria Real Estate Equities Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 5.1%. The ex-dividend date is Wednesday, September 30th. Alexandria Real Estate Equities’s payout ratio is -47.52%.

Insider Buying and Selling at Alexandria Real Estate Equities

In other Alexandria Real Estate Equities news, EVP Kristina Fukuzaki-Carlson sold 16,810 shares of the company’s stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $50.51, for a total transaction of $849,073.10. Following the completion of the transaction, the executive vice president owned 39,152 shares of the company’s stock, valued at $1,977,567.52. This represents a 30.04% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO Andres Gavinet sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $50.93, for a total transaction of $509,300.00. Following the transaction, the chief accounting officer directly owned 102,516 shares of the company’s stock, valued at $5,221,139.88. This represents a 8.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 1.35% of the company’s stock.

Institutional Trading of Alexandria Real Estate Equities

Institutional investors have recently made changes to their positions in the business. FNY Investment Advisers LLC acquired a new position in Alexandria Real Estate Equities in the 2nd quarter valued at approximately $26,000. First Bancorp Inc ME acquired a new position in shares of Alexandria Real Estate Equities during the second quarter worth $26,000. Basecamp Wealth Advisors LLC lifted its holdings in shares of Alexandria Real Estate Equities by 3,723.5% during the first quarter. Basecamp Wealth Advisors LLC now owns 650 shares of the real estate investment trust’s stock worth $30,000 after purchasing an additional 633 shares during the period. Danske Bank A S bought a new stake in shares of Alexandria Real Estate Equities in the second quarter worth $42,000. Finally, SJS Investment Consulting Inc. grew its stake in shares of Alexandria Real Estate Equities by 38.7% in the first quarter. SJS Investment Consulting Inc. now owns 1,150 shares of the real estate investment trust’s stock worth $53,000 after purchasing an additional 321 shares during the last quarter. Institutional investors own 96.54% of the company’s stock.

About Alexandria Real Estate Equities

Alexandria Real Estate Equities, Inc (NYSE:ARE) is a real estate investment trust that owns, operates and develops collaborative life science, agtech and advanced technology campuses. The company provides specialized laboratory, research and office space designed to support organizations working in biotechnology, pharmaceuticals, medical devices, diagnostics, agriculture and related technology fields.

Founded in 1994, Alexandria focuses on properties located in established innovation clusters, where its campuses bring together research institutions, universities, hospitals, government agencies, start-ups and established companies.